These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 3065058)

  • 21. [The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].
    Kukes VG; Rumiantsev AS; Gneushev ET; Al'perovich BR; Svetyĭ LI; Nasyrov MN; Taratuta TV
    Ter Arkh; 1990; 62(10):138-42. PubMed ID: 2084878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
    Kumar S; Hall RJ
    Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.
    Brogden RN; McTavish D
    Drugs; 1995 Sep; 50(3):495-512. PubMed ID: 8521771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
    Levine MA; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1988 Jan; 43(1):39-48. PubMed ID: 2826066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actions of nisoldipine in cardiovascular disease.
    Duncker DJ; Van Woerkens LJ; Serruys PW; Roelandt JR; Hugenholtz PG; Verdouw PD
    Can J Cardiol; 1989; 5(5):266-74. PubMed ID: 2667729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
    Croom KF; Wellington K
    Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
    Freedman DD; Waters DD
    Drugs; 1987 Nov; 34(5):578-98. PubMed ID: 3319491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine in the treatment of cardiovascular disease.
    Mueller HS; Antman EM; Ferst JA; Muller JE
    Pharmacotherapy; 1981; 1(2):78-94. PubMed ID: 6100818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
    Donaldson KM; Dawkins KD; Waller DG
    Br J Clin Pharmacol; 1993 Oct; 36(4):315-21. PubMed ID: 12959309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris.
    Rousseau MF; Vincent MF; Van Hoof F; Van den Berghe G; Charlier AA; Pouleur H
    Am J Cardiol; 1984 Dec; 54(10):1189-94. PubMed ID: 6507289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction.
    Lewis BS
    Am J Cardiol; 1995 Apr; 75(13):46E-53E. PubMed ID: 7726125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
    Lam J; Chaitman BR; Crean P; Blum R; Waters DD
    J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect].
    Heynen G
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):199-203. PubMed ID: 1531545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
    Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
    J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.
    Plosker GL; Faulds D
    Drugs; 1996 Aug; 52(2):232-53. PubMed ID: 8841741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.